ArticleACG case reports journal2026
A Rare Case of Giant Cell Hepatitis Superimposed on Sickle Cell Hepatopathy.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell hepatitis (GCH) is a rare histopathologic pattern of liver injury characterized by multinucleated syncytial hepatocytes within inflamed parenchyma and is a pattern most commonly seen in infants rather than adults. We report a case of levofloxacin-induced GCH superimposed on sickle cell hepatopathy in a 20-year-old woman with sickle cell disease. She presented with recurrent transaminitis and severe hyperbilirubinemia shortly after initiation of levofloxacin. Liver biopsy revealed sinusoidal congestion and fibrosis consistent with sickle cell hepatopathy, along with portal inflammation, bile duct injury, and multinucleated hepatocytes diagnostic of GCH. Prednisone therapy was started, which led to marked biochemical and histologic improvement, and subsequent resolution of GCH on repeat biopsy. This case emphasizes the diagnostic utility of liver biopsy in sickle cell disease in medical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.